연구용
제품 번호S1078
| 세포주 | 분석 유형 | 농도 | 배양 시간 | 제형 | 활성 설명 | PMID |
|---|---|---|---|---|---|---|
| NCI-H1650 | Growth Inhibition Assay | IC50=22.764 μM | SANGER | |||
| AM-38 | Growth Inhibition Assay | IC50=22.8689 μM | SANGER | |||
| NCI-H2405 | Growth Inhibition Assay | IC50=23.2533 μM | SANGER | |||
| M14 | Growth Inhibition Assay | IC50=23.4088 μM | SANGER | |||
| ES4 | Growth Inhibition Assay | IC50=23.4232 μM | SANGER | |||
| DJM-1 | Growth Inhibition Assay | IC50=23.5234 μM | SANGER | |||
| S-117 | Growth Inhibition Assay | IC50=23.7651 μM | SANGER | |||
| MZ2-MEL | Growth Inhibition Assay | IC50=23.7759 μM | SANGER | |||
| SK-MEL-2 | Growth Inhibition Assay | IC50=23.8133 μM | SANGER | |||
| HCC1806 | Growth Inhibition Assay | IC50=23.8709 μM | SANGER | |||
| NMC-G1 | Growth Inhibition Assay | IC50=24.2226 μM | SANGER | |||
| DK-MG | Growth Inhibition Assay | IC50=24.294 μM | SANGER | |||
| SK-N-FI | Growth Inhibition Assay | IC50=24.3302 μM | SANGER | |||
| KINGS-1 | Growth Inhibition Assay | IC50=24.4874 μM | SANGER | |||
| HCC2998 | Growth Inhibition Assay | IC50=24.4885 μM | SANGER | |||
| ALL-PO | Growth Inhibition Assay | IC50=24.619 μM | SANGER | |||
| MPP-89 | Growth Inhibition Assay | IC50=25.0458 μM | SANGER | |||
| NCI-H2342 | Growth Inhibition Assay | IC50=25.1953 μM | SANGER | |||
| TE-1 | Growth Inhibition Assay | IC50=25.3563 μM | SANGER | |||
| RH-18 | Growth Inhibition Assay | IC50=25.5918 μM | SANGER | |||
| HT-1376 | Growth Inhibition Assay | IC50=25.6465 μM | SANGER | |||
| U-2-OS | Growth Inhibition Assay | IC50=25.6888 μM | SANGER | |||
| BT-549 | Growth Inhibition Assay | IC50=25.9011 μM | SANGER | |||
| NCI-H1755 | Growth Inhibition Assay | IC50=25.9945 μM | SANGER | |||
| EW-13 | Growth Inhibition Assay | IC50=26.0274 μM | SANGER | |||
| NB13 | Growth Inhibition Assay | IC50=26.0949 μM | SANGER | |||
| NUGC-3 | Growth Inhibition Assay | IC50=26.2103 μM | SANGER | |||
| GMS-10 | Growth Inhibition Assay | IC50=26.2353 μM | SANGER | |||
| CHP-134 | Growth Inhibition Assay | IC50=26.3867 μM | SANGER | |||
| SW962 | Growth Inhibition Assay | IC50=26.5021 μM | SANGER | |||
| SNU-449 | Growth Inhibition Assay | IC50=27.0803 μM | SANGER | |||
| HuP-T4 | Growth Inhibition Assay | IC50=27.0879 μM | SANGER | |||
| SW948 | Growth Inhibition Assay | IC50=27.1344 μM | SANGER | |||
| NCI-H226 | Growth Inhibition Assay | IC50=27.4578 μM | SANGER | |||
| SK-PN-DW | Growth Inhibition Assay | IC50=27.6012 μM | SANGER | |||
| GI-1 | Growth Inhibition Assay | IC50=27.721 μM | SANGER | |||
| CAL-12T | Growth Inhibition Assay | IC50=28.1112 μM | SANGER | |||
| YAPC | Growth Inhibition Assay | IC50=28.2564 μM | SANGER | |||
| SNU-C2B | Growth Inhibition Assay | IC50=28.2964 μM | SANGER | |||
| RCC10RGB | Growth Inhibition Assay | IC50=28.5417 μM | SANGER | |||
| ES7 | Growth Inhibition Assay | IC50=29.1465 μM | SANGER | |||
| PANC-03-27 | Growth Inhibition Assay | IC50=29.444 μM | SANGER | |||
| ES6 | Growth Inhibition Assay | IC50=29.8157 μM | SANGER | |||
| HT-1197 | Growth Inhibition Assay | IC50=30.0598 μM | SANGER | |||
| ZR-75-30 | Growth Inhibition Assay | IC50=30.2383 μM | SANGER | |||
| DB | Growth Inhibition Assay | IC50=30.4942 μM | SANGER | |||
| OCI-AML2 | Growth Inhibition Assay | IC50=31.069 μM | SANGER | |||
| NCI-H2170 | Growth Inhibition Assay | IC50=31.8516 μM | SANGER | |||
| IST-MES1 | Growth Inhibition Assay | IC50=32.2897 μM | SANGER | |||
| 769-P | Growth Inhibition Assay | IC50=32.3641 μM | SANGER | |||
| COR-L23 | Growth Inhibition Assay | IC50=32.9073 μM | SANGER | |||
| SW626 | Growth Inhibition Assay | IC50=33.1776 μM | SANGER | |||
| LU-139 | Growth Inhibition Assay | IC50=33.6605 μM | SANGER | |||
| HT-144 | Growth Inhibition Assay | IC50=33.863 μM | SANGER | |||
| CaR-1 | Growth Inhibition Assay | IC50=33.9822 μM | SANGER | |||
| OE33 | Growth Inhibition Assay | IC50=34.2855 μM | SANGER | |||
| COLO-800 | Growth Inhibition Assay | IC50=34.3647 μM | SANGER | |||
| NB14 | Growth Inhibition Assay | IC50=34.4684 μM | SANGER | |||
| KURAMOCHI | Growth Inhibition Assay | IC50=36.1198 μM | SANGER | |||
| SW48 | Growth Inhibition Assay | IC50=36.2474 μM | SANGER | |||
| Daoy | Growth Inhibition Assay | IC50=36.6538 μM | SANGER | |||
| TGBC24TKB | Growth Inhibition Assay | IC50=36.67 μM | SANGER | |||
| DU-4475 | Growth Inhibition Assay | IC50=36.9033 μM | SANGER | |||
| SW1417 | Growth Inhibition Assay | IC50=38.0552 μM | SANGER | |||
| EFO-21 | Growth Inhibition Assay | IC50=38.9349 μM | SANGER | |||
| MG-63 | Growth Inhibition Assay | IC50=39.3424 μM | SANGER | |||
| LC-2-ad | Growth Inhibition Assay | IC50=39.5512 μM | SANGER | |||
| NOMO-1 | Growth Inhibition Assay | IC50=39.8274 μM | SANGER | |||
| COLO-741 | Growth Inhibition Assay | IC50=40.1304 μM | SANGER | |||
| BxPC-3 | Growth Inhibition Assay | IC50=40.5686 μM | SANGER | |||
| HSC-2 | Growth Inhibition Assay | IC50=40.9113 μM | SANGER | |||
| UMC-11 | Growth Inhibition Assay | IC50=41.263 μM | SANGER | |||
| HCC1937 | Growth Inhibition Assay | IC50=42.7843 μM | SANGER | |||
| Calu-6 | Growth Inhibition Assay | IC50=43.2382 μM | SANGER | |||
| NCI-H1573 | Growth Inhibition Assay | IC50=43.3477 μM | SANGER | |||
| SK-N-AS | Growth Inhibition Assay | IC50=43.6019 μM | SANGER | |||
| PSN1 | Growth Inhibition Assay | IC50=45.2548 μM | SANGER | |||
| TE-11 | Growth Inhibition Assay | IC50=45.4842 μM | SANGER | |||
| NCI-H1155 | Growth Inhibition Assay | IC50=45.8967 μM | SANGER | |||
| KM12 | Growth Inhibition Assay | IC50=45.9076 μM | SANGER | |||
| RO82-W-1 | Growth Inhibition Assay | IC50=46.9822 μM | SANGER | |||
| SW1573 | Growth Inhibition Assay | IC50=47.3736 μM | SANGER | |||
| CAKI-1 | Growth Inhibition Assay | IC50=48.2845 μM | SANGER | |||
| U-118-MG | Growth Inhibition Assay | IC50=48.3702 μM | SANGER | |||
| KYSE-520 | Growth Inhibition Assay | IC50=48.4016 μM | SANGER | |||
| HT55 | Growth Inhibition Assay | IC50=49.1474 μM | SANGER | |||
| ChaGo-K-1 | Growth Inhibition Assay | IC50=49.4793 μM | SANGER | |||
| IA-LM | Growth Inhibition Assay | IC50=54.6322 μM | SANGER | |||
| UACC-62 | Growth Inhibition Assay | IC50=55.1046 μM | SANGER | |||
| MKN7 | Growth Inhibition Assay | IC50=56.0285 μM | SANGER | |||
| HPAF-II | Growth Inhibition Assay | IC50=56.4073 μM | SANGER | |||
| NTERA-S-cl-D1 | Growth Inhibition Assay | IC50=57.778 μM | SANGER | |||
| FTC-133 | Growth Inhibition Assay | IC50=58.0969 μM | SANGER | |||
| MHH-ES-1 | Growth Inhibition Assay | IC50=58.4814 μM | SANGER | |||
| JVM-2 | Growth Inhibition Assay | IC50=58.9506 μM | SANGER | |||
| TCCSUP | Growth Inhibition Assay | IC50=59.5279 μM | SANGER | |||
| COLO-824 | Growth Inhibition Assay | IC50=60.0719 μM | SANGER | |||
| 647-V | Growth Inhibition Assay | IC50=60.1347 μM | SANGER | |||
| HD-MY-Z | Growth Inhibition Assay | IC50=60.5294 μM | SANGER | |||
| LS-411N | Growth Inhibition Assay | IC50=61.3903 μM | SANGER | |||
| NCI-H596 | Growth Inhibition Assay | IC50=62.7496 μM | SANGER | |||
| C-33-A | Growth Inhibition Assay | IC50=64.0957 μM | SANGER | |||
| BHY | Growth Inhibition Assay | IC50=64.1245 μM | SANGER | |||
| KGN | Growth Inhibition Assay | IC50=64.5514 μM | SANGER | |||
| NCI-H1092 | Growth Inhibition Assay | IC50=65.0095 μM | SANGER | |||
| MZ1-PC | Growth Inhibition Assay | IC50=65.5649 μM | SANGER | |||
| LB831-BLC | Growth Inhibition Assay | IC50=65.8481 μM | SANGER | |||
| SW620 | Growth Inhibition Assay | IC50=66.2039 μM | SANGER | |||
| HuO-3N1 | Growth Inhibition Assay | IC50=68.3238 μM | SANGER | |||
| SK-HEP-1 | Growth Inhibition Assay | IC50=69.9486 μM | SANGER | |||
| LCLC-103H | Growth Inhibition Assay | IC50=70.6705 μM | SANGER | |||
| KYSE-70 | Growth Inhibition Assay | IC50=70.7835 μM | SANGER | |||
| Mewo | Growth Inhibition Assay | IC50=71.505 μM | SANGER | |||
| COLO-668 | Growth Inhibition Assay | IC50=71.8451 μM | SANGER | |||
| NCI-H522 | Growth Inhibition Assay | IC50=72.3413 μM | SANGER | |||
| NCI-H1437 | Growth Inhibition Assay | IC50=74.4048 μM | SANGER | |||
| U-266 | Growth Inhibition Assay | IC50=75.4516 μM | SANGER | |||
| MC116 | Growth Inhibition Assay | IC50=75.5708 μM | SANGER | |||
| PANC-10-05 | Growth Inhibition Assay | IC50=77.4243 μM | SANGER | |||
| KYSE-180 | Growth Inhibition Assay | IC50=77.5454 μM | SANGER | |||
| JAR | Growth Inhibition Assay | IC50=79.0546 μM | SANGER | |||
| CAL-62 | Growth Inhibition Assay | IC50=80.095 μM | SANGER | |||
| A3-KAW | Growth Inhibition Assay | IC50=80.2154 μM | SANGER | |||
| PANC-08-13 | Growth Inhibition Assay | IC50=81.1768 μM | SANGER | |||
| HSC-3 | Growth Inhibition Assay | IC50=83.3071 μM | SANGER | |||
| HTC-C3 | Growth Inhibition Assay | IC50=83.4702 μM | SANGER | |||
| KY821 | Growth Inhibition Assay | IC50=84.0892 μM | SANGER | |||
| DoTc2-4510 | Growth Inhibition Assay | IC50=84.2185 μM | SANGER | |||
| NCI-H1581 | Growth Inhibition Assay | IC50=85.4641 μM | SANGER | |||
| KARPAS-299 | Growth Inhibition Assay | IC50=86.1977 μM | SANGER | |||
| IST-MEL1 | Growth Inhibition Assay | IC50=86.8872 μM | SANGER | |||
| KP-N-YS | Growth Inhibition Assay | IC50=89.9028 μM | SANGER | |||
| KYSE-410 | Growth Inhibition Assay | IC50=91.4042 μM | SANGER | |||
| TE-10 | Growth Inhibition Assay | IC50=91.5611 μM | SANGER | |||
| SK-MEL-1 | Growth Inhibition Assay | IC50=92.9106 μM | SANGER | |||
| COLO-792 | Growth Inhibition Assay | IC50=95.2564 μM | SANGER | |||
| SCH | Growth Inhibition Assay | IC50=96.3877 μM | SANGER | |||
| NCI-H1792 | Growth Inhibition Assay | IC50=96.8992 μM | SANGER | |||
| NCI-H2029 | Growth Inhibition Assay | IC50=96.9566 μM | SANGER | |||
| SW684 | Growth Inhibition Assay | IC50=98.6654 μM | SANGER | |||
| NCI-H209 | Growth Inhibition Assay | IC50=100.121 μM | SANGER | |||
| HLE | Growth Inhibition Assay | IC50=105.282 μM | SANGER | |||
| GOTO | Growth Inhibition Assay | IC50=107.777 μM | SANGER | |||
| NCI-H1793 | Growth Inhibition Assay | IC50=109.28 μM | SANGER | |||
| D-392MG | Growth Inhibition Assay | IC50=117.398 μM | SANGER | |||
| SW1990 | Growth Inhibition Assay | IC50=120.951 μM | SANGER | |||
| ML-2 | Growth Inhibition Assay | IC50=121.676 μM | SANGER | |||
| SK-MEL-30 | Growth Inhibition Assay | IC50=123.244 μM | SANGER | |||
| NCI-H2452 | Growth Inhibition Assay | IC50=122.21 μM | SANGER | |||
| NCI-H1770 | Growth Inhibition Assay | IC50=125.514 μM | SANGER | |||
| SN12C | Growth Inhibition Assay | IC50=124.176 μM | SANGER | |||
| SF268 | Growth Inhibition Assay | IC50=126.158 μM | SANGER | |||
| COLO-679 | Growth Inhibition Assay | IC50=126.753 μM | SANGER | |||
| BALL-1 | Growth Inhibition Assay | IC50=126.23 μM | SANGER | |||
| A2780 | Growth Inhibition Assay | IC50=128.988 μM | SANGER | |||
| NCI-H1651 | Growth Inhibition Assay | IC50=131.243 μM | SANGER | |||
| NCI-H2087 | Growth Inhibition Assay | IC50=131.483 μM | SANGER | |||
| U-87-MG | Growth Inhibition Assay | IC50=133.604 μM | SANGER | |||
| LB2518-MEL | Growth Inhibition Assay | IC50=135.993 μM | SANGER | |||
| HCT-116 | Growth Inhibition Assay | IC50=137.217 μM | SANGER | |||
| Ca9-22 | Growth Inhibition Assay | IC50=139.833 μM | SANGER | |||
| COR-L88 | Growth Inhibition Assay | IC50=142.14 μM | SANGER | |||
| CP50-MEL-B | Growth Inhibition Assay | IC50=144.501 μM | SANGER | |||
| OVCAR-8 | Growth Inhibition Assay | IC50=145.636 μM | SANGER | |||
| SK-MEL-3 | Growth Inhibition Assay | IC50=147.878 μM | SANGER | |||
| GT3TKB | Growth Inhibition Assay | IC50=149.928 μM | SANGER | |||
| KYSE-450 | Growth Inhibition Assay | IC50=151.539 μM | SANGER | |||
| BEN | Growth Inhibition Assay | IC50=153.928 μM | SANGER | |||
| CAPAN-1 | Growth Inhibition Assay | IC50=153.064 μM | SANGER | |||
| NCI-H1304 | Growth Inhibition Assay | IC50=154.694 μM | SANGER | |||
| KU812 | Growth Inhibition Assay | IC50=158.674 μM | SANGER | |||
| Capan-2 | Growth Inhibition Assay | IC50=160.553 μM | SANGER | |||
| SAS | Growth Inhibition Assay | IC50=162.678 μM | SANGER | |||
| A673 | Growth Inhibition Assay | IC50=161.705 μM | SANGER | |||
| NY | Growth Inhibition Assay | IC50=165.314 μM | SANGER | |||
| HCE-4 | Growth Inhibition Assay | IC50=166.845 μM | SANGER | |||
| MDA-MB-231 | Growth Inhibition Assay | IC50=177.503 μM | SANGER | |||
| no-10 | Growth Inhibition Assay | IC50=178.134 μM | SANGER | |||
| MZ7-mel | Growth Inhibition Assay | IC50=178.467 μM | SANGER | |||
| NCI-H82 | Growth Inhibition Assay | IC50=180.165 μM | SANGER | |||
| CAL-72 | Growth Inhibition Assay | IC50=185.054 μM | SANGER | |||
| NCI-SNU-5 | Growth Inhibition Assay | IC50=186.84 μM | SANGER | |||
| OVCAR-4 | Growth Inhibition Assay | IC50=188.333 μM | SANGER | |||
| KYSE-150 | Growth Inhibition Assay | IC50=191.888 μM | SANGER | |||
| SCC-9 | Growth Inhibition Assay | IC50=191 μM | SANGER | |||
| HT-29 | Growth Inhibition Assay | IC50=201.212 μM | SANGER | |||
| COLO-678 | Growth Inhibition Assay | IC50=201.45 μM | SANGER | |||
| NCI-H650 | Growth Inhibition Assay | IC50=202.103 μM | SANGER | |||
| HuCCT1 | Growth Inhibition Assay | IC50=204.208 μM | SANGER | |||
| SW1116 | Growth Inhibition Assay | IC50=207.077 μM | SANGER | |||
| SW982 | Growth Inhibition Assay | IC50=207.948 μM | SANGER | |||
| DBTRG-05MG | Growth Inhibition Assay | IC50=207.909 μM | SANGER | |||
| RCM-1 | Growth Inhibition Assay | IC50=214.762 μM | SANGER | |||
| KNS-42 | Growth Inhibition Assay | IC50=216.574 μM | SANGER | |||
| COLO-320-HSR | Growth Inhibition Assay | IC50=216.125 μM | SANGER | |||
| C2BBe1 | Growth Inhibition Assay | IC50=231.905 μM | SANGER | |||
| CCRF-CEM | Growth Inhibition Assay | IC50=243.795 μM | SANGER | |||
| SH-4 | Growth Inhibition Assay | IC50=246.09 μM | SANGER | |||
| LS-1034 | Growth Inhibition Assay | IC50=246.266 μM | SANGER | |||
| NCI-H2347 | Growth Inhibition Assay | IC50=247.713 μM | SANGER | |||
| RPMI-8866 | Growth Inhibition Assay | IC50=249.27 μM | SANGER | |||
| GAK | Growth Inhibition Assay | IC50=253.002 μM | SANGER | |||
| NB6 | Growth Inhibition Assay | IC50=270.1 μM | SANGER | |||
| COLO-680N | Growth Inhibition Assay | IC50=272.527 μM | SANGER | |||
| RERF-LC-MS | Growth Inhibition Assay | IC50=276.007 μM | SANGER | |||
| TGBC11TKB | Growth Inhibition Assay | IC50=278.178 μM | SANGER | |||
| C8166 | Growth Inhibition Assay | IC50=278.506 μM | SANGER | |||
| HDLM-2 | Growth Inhibition Assay | IC50=294.409 μM | SANGER | |||
| IGR-1 | Growth Inhibition Assay | IC50=295.659 μM | SANGER | |||
| FADU | Growth Inhibition Assay | IC50=297.51 μM | SANGER | |||
| L-428 | Growth Inhibition Assay | IC50=297.616 μM | SANGER | |||
| LU-65 | Growth Inhibition Assay | IC50=304.32 μM | SANGER | |||
| NCI-H810 | Growth Inhibition Assay | IC50=310.57 μM | SANGER | |||
| HEL | Growth Inhibition Assay | IC50=309.983 μM | SANGER | |||
| C3A | Growth Inhibition Assay | IC50=311.802 μM | SANGER | |||
| KP-N-YN | Growth Inhibition Assay | IC50=341.123 μM | SANGER | |||
| NCI-H630 | Growth Inhibition Assay | IC50=332.294 μM | SANGER | |||
| MOLT-13 | Growth Inhibition Assay | IC50=342.326 μM | SANGER | |||
| NCI-H1993 | Growth Inhibition Assay | IC50=342.365 μM | SANGER | |||
| BE-13 | Growth Inhibition Assay | IC50=344.167 μM | SANGER | |||
| IST-SL1 | Growth Inhibition Assay | IC50=347.401 μM | SANGER | |||
| TE-9 | Growth Inhibition Assay | IC50=363.589 μM | SANGER | |||
| LU-135 | Growth Inhibition Assay | IC50=367.035 μM | SANGER | |||
| T84 | Growth Inhibition Assay | IC50=374.712 μM | SANGER | |||
| K-562 | Growth Inhibition Assay | IC50=383.36 μM | SANGER | |||
| SBC-5 | Growth Inhibition Assay | IC50=386.985 μM | SANGER | |||
| NB17 | Growth Inhibition Assay | IC50=392.596 μM | SANGER | |||
| NCI-H2052 | Growth Inhibition Assay | IC50=398.472 μM | SANGER | |||
| HCC38 | Growth Inhibition Assay | IC50=401.593 μM | SANGER | |||
| NCI-H69 | Growth Inhibition Assay | IC50=441.083 μM | SANGER | |||
| NCI-H526 | Growth Inhibition Assay | IC50=22.3895 μM | SANGER | |||
| NCI-H2122 | Growth Inhibition Assay | IC50=22.2432 μM | SANGER | |||
| KU-19-19 | Growth Inhibition Assay | IC50=22.1697 μM | SANGER | |||
| NCI-H661 | Growth Inhibition Assay | IC50=22.034 μM | SANGER | |||
| CGTH-W-1 | Growth Inhibition Assay | IC50=21.7166 μM | SANGER | |||
| KYSE-510 | Growth Inhibition Assay | IC50=21.6095 μM | SANGER | |||
| CW-2 | Growth Inhibition Assay | IC50=21.6069 μM | SANGER | |||
| LK-2 | Growth Inhibition Assay | IC50=21.5953 μM | SANGER | |||
| 22RV1 | Growth Inhibition Assay | IC50=21.5685 μM | SANGER | |||
| HT-3 | Growth Inhibition Assay | IC50=21.5631 μM | SANGER | |||
| LCLC-97TM1 | Growth Inhibition Assay | IC50=20.8134 μM | SANGER | |||
| NCI-H441 | Growth Inhibition Assay | IC50=20.7379 μM | SANGER | |||
| MIA-PaCa-2 | Growth Inhibition Assay | IC50=20.6883 μM | SANGER | |||
| HT-1080 | Growth Inhibition Assay | IC50=20.5497 μM | SANGER | |||
| NCI-H1355 | Growth Inhibition Assay | IC50=20.3374 μM | SANGER | |||
| Mo-T | Growth Inhibition Assay | IC50=20.1665 μM | SANGER | |||
| HL-60 | Growth Inhibition Assay | IC50=20.0941 μM | SANGER | |||
| KYSE-270 | Growth Inhibition Assay | IC50=20.0217 μM | SANGER | |||
| TE-8 | Growth Inhibition Assay | IC50=19.3024 μM | SANGER | |||
| 8305C | Growth Inhibition Assay | IC50=19.2286 μM | SANGER | |||
| GI-ME-N | Growth Inhibition Assay | IC50=19.1546 μM | SANGER | |||
| 8-MG-BA | Growth Inhibition Assay | IC50=19.0646 μM | SANGER | |||
| NCI-N87 | Growth Inhibition Assay | IC50=18.9008 μM | SANGER | |||
| A253 | Growth Inhibition Assay | IC50=18.7286 μM | SANGER | |||
| KM-H2 | Growth Inhibition Assay | IC50=18.5232 μM | SANGER | |||
| C32 | Growth Inhibition Assay | IC50=18.4727 μM | SANGER | |||
| 639-V | Growth Inhibition Assay | IC50=18.3354 μM | SANGER | |||
| CAL-85-1 | Growth Inhibition Assay | IC50=18.2357 μM | SANGER | |||
| EW-1 | Growth Inhibition Assay | IC50=18.1382 μM | SANGER | |||
| MHH-NB-11 | Growth Inhibition Assay | IC50=17.9673 μM | SANGER | |||
| M059J | Growth Inhibition Assay | IC50=17.703 μM | SANGER | |||
| KG-1 | Growth Inhibition Assay | IC50=17.6937 μM | SANGER | |||
| KOSC-2 | Growth Inhibition Assay | IC50=17.6757 μM | SANGER | |||
| UACC-257 | Growth Inhibition Assay | IC50=17.5512 μM | SANGER | |||
| NH-12 | Growth Inhibition Assay | IC50=17.3303 μM | SANGER | |||
| SW1783 | Growth Inhibition Assay | IC50=17.128 μM | SANGER | |||
| LOXIMVI | Growth Inhibition Assay | IC50=17.0707 μM | SANGER | |||
| BB65-RCC | Growth Inhibition Assay | IC50=17.0479 μM | SANGER | |||
| SK-MES-1 | Growth Inhibition Assay | IC50=16.8419 μM | SANGER | |||
| HCC1569 | Growth Inhibition Assay | IC50=16.8337 μM | SANGER | |||
| Detroit562 | Growth Inhibition Assay | IC50=16.7318 μM | SANGER | |||
| SK-LU-1 | Growth Inhibition Assay | IC50=16.6956 μM | SANGER | |||
| HuP-T3 | Growth Inhibition Assay | IC50=16.6373 μM | SANGER | |||
| MDA-MB-453 | Growth Inhibition Assay | IC50=16.1642 μM | SANGER | |||
| BFTC-905 | Growth Inhibition Assay | IC50=15.7694 μM | SANGER | |||
| SiHa | Growth Inhibition Assay | IC50=15.7594 μM | SANGER | |||
| NCI-H727 | Growth Inhibition Assay | IC50=15.4221 μM | SANGER | |||
| CAS-1 | Growth Inhibition Assay | IC50=15.4184 μM | SANGER | |||
| OE19 | Growth Inhibition Assay | IC50=15.1541 μM | SANGER | |||
| D-283MED | Growth Inhibition Assay | IC50=15.0111 μM | SANGER | |||
| PC-14 | Growth Inhibition Assay | IC50=14.9654 μM | SANGER | |||
| MS-1 | Growth Inhibition Assay | IC50=14.9611 μM | SANGER | |||
| NCI-H23 | Growth Inhibition Assay | IC50=14.7997 μM | SANGER | |||
| CAL-120 | Growth Inhibition Assay | IC50=14.7027 μM | SANGER | |||
| JEG-3 | Growth Inhibition Assay | IC50=14.6326 μM | SANGER | |||
| NCI-H2291 | Growth Inhibition Assay | IC50=14.5878 μM | SANGER | |||
| SW780 | Growth Inhibition Assay | IC50=14.5025 μM | SANGER | |||
| BPH-1 | Growth Inhibition Assay | IC50=14.1664 μM | SANGER | |||
| SCC-15 | Growth Inhibition Assay | IC50=13.9775 μM | SANGER | |||
| CHP-212 | Growth Inhibition Assay | IC50=13.9739 μM | SANGER | |||
| WM-115 | Growth Inhibition Assay | IC50=13.6483 μM | SANGER | |||
| CTV-1 | Growth Inhibition Assay | IC50=13.345 μM | SANGER | |||
| SJSA-1 | Growth Inhibition Assay | IC50=13.2327 μM | SANGER | |||
| HCC1187 | Growth Inhibition Assay | IC50=13.1912 μM | SANGER | |||
| TGBC1TKB | Growth Inhibition Assay | IC50=12.9115 μM | SANGER | |||
| Ca-Ski | Growth Inhibition Assay | IC50=12.9041 μM | SANGER | |||
| KYSE-140 | Growth Inhibition Assay | IC50=12.8595 μM | SANGER | |||
| KNS-81-FD | Growth Inhibition Assay | IC50=12.5869 μM | SANGER | |||
| GCIY | Growth Inhibition Assay | IC50=12.5209 μM | SANGER | |||
| BCPAP | Growth Inhibition Assay | IC50=12.4749 μM | SANGER | |||
| RH-1 | Growth Inhibition Assay | IC50=12.2184 μM | SANGER | |||
| RPMI-7951 | Growth Inhibition Assay | IC50=12.1854 μM | SANGER | |||
| BB49-HNC | Growth Inhibition Assay | IC50=12.1177 μM | SANGER | |||
| CAL-51 | Growth Inhibition Assay | IC50=12.0716 μM | SANGER | |||
| EKVX | Growth Inhibition Assay | IC50=12.0313 μM | SANGER | |||
| CFPAC-1 | Growth Inhibition Assay | IC50=11.9782 μM | SANGER | |||
| D-247MG | Growth Inhibition Assay | IC50=11.9663 μM | SANGER | |||
| GCT | Growth Inhibition Assay | IC50=11.8228 μM | SANGER | |||
| NCI-H1299 | Growth Inhibition Assay | IC50=11.8093 μM | SANGER | |||
| BB30-HNC | Growth Inhibition Assay | IC50=11.7982 μM | SANGER | |||
| MEG-01 | Growth Inhibition Assay | IC50=11.7509 μM | SANGER | |||
| A427 | Growth Inhibition Assay | IC50=11.7093 μM | SANGER | |||
| ONS-76 | Growth Inhibition Assay | IC50=11.636 μM | SANGER | |||
| PC-3 | Growth Inhibition Assay | IC50=11.5764 μM | SANGER | |||
| SW756 | Growth Inhibition Assay | IC50=11.5294 μM | SANGER | |||
| TK10 | Growth Inhibition Assay | IC50=11.5271 μM | SANGER | |||
| SW954 | Growth Inhibition Assay | IC50=11.4668 μM | SANGER | |||
| DEL | Growth Inhibition Assay | IC50=11.424 μM | SANGER | |||
| A388 | Growth Inhibition Assay | IC50=11.3897 μM | SANGER | |||
| SF539 | Growth Inhibition Assay | IC50=10.9041 μM | SANGER | |||
| no-11 | Growth Inhibition Assay | IC50=10.4353 μM | SANGER | |||
| A549 | Growth Inhibition Assay | IC50=10.3973 μM | SANGER | |||
| OVCAR-5 | Growth Inhibition Assay | IC50=10.2433 μM | SANGER | |||
| LAN-6 | Growth Inhibition Assay | IC50=10.2164 μM | SANGER | |||
| YKG-1 | Growth Inhibition Assay | IC50=10.2006 μM | SANGER | |||
| A101D | Growth Inhibition Assay | IC50=9.99974 μM | SANGER | |||
| MDA-MB-157 | Growth Inhibition Assay | IC50=9.92878 μM | SANGER | |||
| 5637 | Growth Inhibition Assay | IC50=9.84984 μM | SANGER | |||
| A431 | Growth Inhibition Assay | IC50=9.80238 μM | SANGER | |||
| U251 | Growth Inhibition Assay | IC50=9.65544 μM | SANGER | |||
| ACN | Growth Inhibition Assay | IC50=9.53277 μM | SANGER | |||
| SHP-77 | Growth Inhibition Assay | IC50=9.39935 μM | SANGER | |||
| LS-123 | Growth Inhibition Assay | IC50=9.31761 μM | SANGER | |||
| NBsusSR | Growth Inhibition Assay | IC50=9.27402 μM | SANGER | |||
| DSH1 | Growth Inhibition Assay | IC50=9.2087 μM | SANGER | |||
| HN | Growth Inhibition Assay | IC50=9.16628 μM | SANGER | |||
| EFO-27 | Growth Inhibition Assay | IC50=9.16412 μM | SANGER | |||
| 8505C | Growth Inhibition Assay | IC50=9.04232 μM | SANGER | |||
| NB10 | Growth Inhibition Assay | IC50=9.02224 μM | SANGER | |||
| HEC-1 | Growth Inhibition Assay | IC50=8.89866 μM | SANGER | |||
| ESS-1 | Growth Inhibition Assay | IC50=8.88704 μM | SANGER | |||
| D-502MG | Growth Inhibition Assay | IC50=8.78629 μM | SANGER | |||
| CAMA-1 | Growth Inhibition Assay | IC50=8.77146 μM | SANGER | |||
| SCC-4 | Growth Inhibition Assay | IC50=8.68219 μM | SANGER | |||
| LB771-HNC | Growth Inhibition Assay | IC50=8.64696 μM | SANGER | |||
| NCI-SNU-1 | Growth Inhibition Assay | IC50=8.64643 μM | SANGER | |||
| SKG-IIIa | Growth Inhibition Assay | IC50=8.63069 μM | SANGER | |||
| LB996-RCC | Growth Inhibition Assay | IC50=8.53257 μM | SANGER | |||
| SF126 | Growth Inhibition Assay | IC50=8.45936 μM | SANGER | |||
| HCC1954 | Growth Inhibition Assay | IC50=8.45104 μM | SANGER | |||
| T98G | Growth Inhibition Assay | IC50=8.18067 μM | SANGER | |||
| JVM-3 | Growth Inhibition Assay | IC50=8.15268 μM | SANGER | |||
| D-566MG | Growth Inhibition Assay | IC50=8.04429 μM | SANGER | |||
| TE-5 | Growth Inhibition Assay | IC50=7.79334 μM | SANGER | |||
| MSTO-211H | Growth Inhibition Assay | IC50=7.67336 μM | SANGER | |||
| CAL-33 | Growth Inhibition Assay | IC50=7.66233 μM | SANGER | |||
| GB-1 | Growth Inhibition Assay | IC50=7.54804 μM | SANGER | |||
| GP5d | Growth Inhibition Assay | IC50=7.48764 μM | SANGER | |||
| MC-IXC | Growth Inhibition Assay | IC50=7.48576 μM | SANGER | |||
| NCI-H28 | Growth Inhibition Assay | IC50=7.2924 μM | SANGER | |||
| LU-99A | Growth Inhibition Assay | IC50=7.14322 μM | SANGER | |||
| SW1463 | Growth Inhibition Assay | IC50=7.11168 μM | SANGER | |||
| RD | Growth Inhibition Assay | IC50=6.98284 μM | SANGER | |||
| AU565 | Growth Inhibition Assay | IC50=6.96957 μM | SANGER | |||
| TE-6 | Growth Inhibition Assay | IC50=6.93038 μM | SANGER | |||
| TE-12 | Growth Inhibition Assay | IC50=6.83817 μM | SANGER | |||
| A498 | Growth Inhibition Assay | IC50=6.81961 μM | SANGER | |||
| CHL-1 | Growth Inhibition Assay | IC50=6.80079 μM | SANGER | |||
| LN-405 | Growth Inhibition Assay | IC50=6.79672 μM | SANGER | |||
| NCI-H1693 | Growth Inhibition Assay | IC50=6.63604 μM | SANGER | |||
| A704 | Growth Inhibition Assay | IC50=6.6306 μM | SANGER | |||
| SNB75 | Growth Inhibition Assay | IC50=6.60143 μM | SANGER | |||
| D-263MG | Growth Inhibition Assay | IC50=6.45169 μM | SANGER | |||
| NB12 | Growth Inhibition Assay | IC50=6.39071 μM | SANGER | |||
| BFTC-909 | Growth Inhibition Assay | IC50=6.30345 μM | SANGER | |||
| BT-474 | Growth Inhibition Assay | IC50=6.233 μM | SANGER | |||
| EW-22 | Growth Inhibition Assay | IC50=6.19649 μM | SANGER | |||
| VMRC-RCZ | Growth Inhibition Assay | IC50=6.08773 μM | SANGER | |||
| SK-OV-3 | Growth Inhibition Assay | IC50=5.99816 μM | SANGER | |||
| Saos-2 | Growth Inhibition Assay | IC50=5.8653 μM | SANGER | |||
| Becker | Growth Inhibition Assay | IC50=5.86472 μM | SANGER | |||
| SF295 | Growth Inhibition Assay | IC50=5.80633 μM | SANGER | |||
| PFSK-1 | Growth Inhibition Assay | IC50=5.72732 μM | SANGER | |||
| RPMI-2650 | Growth Inhibition Assay | IC50=5.66199 μM | SANGER | |||
| SW872 | Growth Inhibition Assay | IC50=5.59428 μM | SANGER | |||
| CAL-27 | Growth Inhibition Assay | IC50=5.46339 μM | SANGER | |||
| MEL-HO | Growth Inhibition Assay | IC50=5.37336 μM | SANGER | |||
| BT-20 | Growth Inhibition Assay | IC50=5.21353 μM | SANGER | |||
| ETK-1 | Growth Inhibition Assay | IC50=5.21165 μM | SANGER | |||
| NCI-H446 | Growth Inhibition Assay | IC50=5.20009 μM | SANGER | |||
| SK-N-DZ | Growth Inhibition Assay | IC50=4.96142 μM | SANGER | |||
| 786-0 | Growth Inhibition Assay | IC50=4.94673 μM | SANGER | |||
| HO-1-N-1 | Growth Inhibition Assay | IC50=4.942 μM | SANGER | |||
| TI-73 | Growth Inhibition Assay | IC50=4.80609 μM | SANGER | |||
| CAL-39 | Growth Inhibition Assay | IC50=4.72146 μM | SANGER | |||
| KLE | Growth Inhibition Assay | IC50=4.70198 μM | SANGER | |||
| NB5 | Growth Inhibition Assay | IC50=4.53697 μM | SANGER | |||
| ATN-1 | Growth Inhibition Assay | IC50=4.44304 μM | SANGER | |||
| EW-11 | Growth Inhibition Assay | IC50=4.41838 μM | SANGER | |||
| HCE-T | Growth Inhibition Assay | IC50=4.41579 μM | SANGER | |||
| NCI-H292 | Growth Inhibition Assay | IC50=4.38146 μM | SANGER | |||
| EGI-1 | Growth Inhibition Assay | IC50=4.37778 μM | SANGER | |||
| NCI-H460 | Growth Inhibition Assay | IC50=4.26443 μM | SANGER | |||
| Calu-3 | Growth Inhibition Assay | IC50=4.24416 μM | SANGER | |||
| LAMA-84 | Growth Inhibition Assay | IC50=4.14191 μM | SANGER | |||
| TYK-nu | Growth Inhibition Assay | IC50=4.09534 μM | SANGER | |||
| SCC-25 | Growth Inhibition Assay | IC50=4.06566 μM | SANGER | |||
| MLMA | Growth Inhibition Assay | IC50=4.02966 μM | SANGER | |||
| TGW | Growth Inhibition Assay | IC50=4.02305 μM | SANGER | |||
| ECC10 | Growth Inhibition Assay | IC50=3.93622 μM | SANGER | |||
| LU-134-A | Growth Inhibition Assay | IC50=3.88428 μM | SANGER | |||
| RVH-421 | Growth Inhibition Assay | IC50=3.81788 μM | SANGER | |||
| P30-OHK | Growth Inhibition Assay | IC50=3.80976 μM | SANGER | |||
| MHH-PREB-1 | Growth Inhibition Assay | IC50=3.72038 μM | SANGER | |||
| G-402 | Growth Inhibition Assay | IC50=3.70711 μM | SANGER | |||
| SJRH30 | Growth Inhibition Assay | IC50=3.69122 μM | SANGER | |||
| KNS-62 | Growth Inhibition Assay | IC50=3.63338 μM | SANGER | |||
| AN3-CA | Growth Inhibition Assay | IC50=3.62456 μM | SANGER | |||
| DMS-114 | Growth Inhibition Assay | IC50=3.62278 μM | SANGER | |||
| RT-112 | Growth Inhibition Assay | IC50=3.52388 μM | SANGER | |||
| SW1710 | Growth Inhibition Assay | IC50=3.46678 μM | SANGER | |||
| H4 | Growth Inhibition Assay | IC50=3.45626 μM | SANGER | |||
| NCI-H1623 | Growth Inhibition Assay | IC50=3.41224 μM | SANGER | |||
| OVCAR-3 | Growth Inhibition Assay | IC50=3.40786 μM | SANGER | |||
| HCC2157 | Growth Inhibition Assay | IC50=3.38179 μM | SANGER | |||
| DOK | Growth Inhibition Assay | IC50=3.22859 μM | SANGER | |||
| EW-16 | Growth Inhibition Assay | IC50=3.21879 μM | SANGER | |||
| NCI-H747 | Growth Inhibition Assay | IC50=3.20694 μM | SANGER | |||
| EW-3 | Growth Inhibition Assay | IC50=3.19529 μM | SANGER | |||
| OS-RC-2 | Growth Inhibition Assay | IC50=3.1119 μM | SANGER | |||
| HuH-7 | Growth Inhibition Assay | IC50=3.09464 μM | SANGER | |||
| EoL-1- | Growth Inhibition Assay | IC50=3.07058 μM | SANGER | |||
| GR-ST | Growth Inhibition Assay | IC50=3.04611 μM | SANGER | |||
| NCI-H1048 | Growth Inhibition Assay | IC50=2.96865 μM | SANGER | |||
| SNU-423 | Growth Inhibition Assay | IC50=2.89242 μM | SANGER | |||
| MCF7 | Growth Inhibition Assay | IC50=2.86117 μM | SANGER | |||
| A204 | Growth Inhibition Assay | IC50=2.83872 μM | SANGER | |||
| MV-4-11 | Growth Inhibition Assay | IC50=2.75266 μM | SANGER | |||
| HCC1395 | Growth Inhibition Assay | IC50=2.75187 μM | SANGER | |||
| AGS | Growth Inhibition Assay | IC50=2.72137 μM | SANGER | |||
| RPMI-8226 | Growth Inhibition Assay | IC50=2.62953 μM | SANGER | |||
| RXF393 | Growth Inhibition Assay | IC50=2.60487 μM | SANGER | |||
| ES3 | Growth Inhibition Assay | IC50=2.49759 μM | SANGER | |||
| ES8 | Growth Inhibition Assay | IC50=2.49287 μM | SANGER | |||
| T-24 | Growth Inhibition Assay | IC50=2.47881 μM | SANGER | |||
| YH-13 | Growth Inhibition Assay | IC50=2.46153 μM | SANGER | |||
| EW-18 | Growth Inhibition Assay | IC50=2.41939 μM | SANGER | |||
| D-423MG | Growth Inhibition Assay | IC50=2.41044 μM | SANGER | |||
| VM-CUB-1 | Growth Inhibition Assay | IC50=2.39083 μM | SANGER | |||
| NB69 | Growth Inhibition Assay | IC50=2.38983 μM | SANGER | |||
| KS-1 | Growth Inhibition Assay | IC50=2.38191 μM | SANGER | |||
| LS-513 | Growth Inhibition Assay | IC50=2.33484 μM | SANGER | |||
| ABC-1 | Growth Inhibition Assay | IC50=2.33253 μM | SANGER | |||
| NCI-H2228 | Growth Inhibition Assay | IC50=2.31552 μM | SANGER | |||
| OAW-28 | Growth Inhibition Assay | IC50=2.29951 μM | SANGER | |||
| MN-60 | Growth Inhibition Assay | IC50=2.29923 μM | SANGER | |||
| LB1047-RCC | Growth Inhibition Assay | IC50=2.24317 μM | SANGER | |||
| GAMG | Growth Inhibition Assay | IC50=2.23845 μM | SANGER | |||
| NCI-H1395 | Growth Inhibition Assay | IC50=2.18091 μM | SANGER | |||
| RMG-I | Growth Inhibition Assay | IC50=2.16398 μM | SANGER | |||
| OC-314 | Growth Inhibition Assay | IC50=2.15086 μM | SANGER | |||
| Hs-578-T | Growth Inhibition Assay | IC50=2.11433 μM | SANGER | |||
| SW1088 | Growth Inhibition Assay | IC50=1.94606 μM | SANGER | |||
| SNU-387 | Growth Inhibition Assay | IC50=1.88406 μM | SANGER | |||
| RKO | Growth Inhibition Assay | IC50=1.87101 μM | SANGER | |||
| BV-173 | Growth Inhibition Assay | IC50=1.81074 μM | SANGER | |||
| COR-L105 | Growth Inhibition Assay | IC50=1.79737 μM | SANGER | |||
| OMC-1 | Growth Inhibition Assay | IC50=1.74677 μM | SANGER | |||
| CAL-54 | Growth Inhibition Assay | IC50=1.71242 μM | SANGER | |||
| HCC2218 | Growth Inhibition Assay | IC50=1.68225 μM | SANGER | |||
| ME-180 | Growth Inhibition Assay | IC50=1.56891 μM | SANGER | |||
| DMS-273 | Growth Inhibition Assay | IC50=1.51959 μM | SANGER | |||
| HOS | Growth Inhibition Assay | IC50=1.49558 μM | SANGER | |||
| QIMR-WIL | Growth Inhibition Assay | IC50=1.49116 μM | SANGER | |||
| 697 | Growth Inhibition Assay | IC50=1.37616 μM | SANGER | |||
| PA-1 | Growth Inhibition Assay | IC50=1.35265 μM | SANGER | |||
| MFM-223 | Growth Inhibition Assay | IC50=1.34461 μM | SANGER | |||
| Ramos-2G6-4C10 | Growth Inhibition Assay | IC50=1.33701 μM | SANGER | |||
| LoVo | Growth Inhibition Assay | IC50=1.32534 μM | SANGER | |||
| G-401 | Growth Inhibition Assay | IC50=1.29795 μM | SANGER | |||
| CTB-1 | Growth Inhibition Assay | IC50=1.2899 μM | SANGER | |||
| DOHH-2 | Growth Inhibition Assay | IC50=1.28203 μM | SANGER | |||
| ES1 | Growth Inhibition Assay | IC50=1.24065 μM | SANGER | |||
| COLO-684 | Growth Inhibition Assay | IC50=1.23725 μM | SANGER | |||
| EPLC-272H | Growth Inhibition Assay | IC50=1.17256 μM | SANGER | |||
| LXF-289 | Growth Inhibition Assay | IC50=1.17156 μM | SANGER | |||
| SK-NEP-1 | Growth Inhibition Assay | IC50=1.14485 μM | SANGER | |||
| LB2241-RCC | Growth Inhibition Assay | IC50=0.99734 μM | SANGER | |||
| NCI-H520 | Growth Inhibition Assay | IC50=0.98592 μM | SANGER | |||
| EM-2 | Growth Inhibition Assay | IC50=0.97939 μM | SANGER | |||
| MFE-280 | Growth Inhibition Assay | IC50=0.96465 μM | SANGER | |||
| HuO9 | Growth Inhibition Assay | IC50=0.92751 μM | SANGER | |||
| OAW-42 | Growth Inhibition Assay | IC50=0.8872 μM | SANGER | |||
| HOP-92 | Growth Inhibition Assay | IC50=0.87223 μM | SANGER | |||
| NKM-1 | Growth Inhibition Assay | IC50=0.86253 μM | SANGER | |||
| L-363 | Growth Inhibition Assay | IC50=0.83442 μM | SANGER | |||
| NB7 | Growth Inhibition Assay | IC50=0.82411 μM | SANGER | |||
| MOLT-4 | Growth Inhibition Assay | IC50=0.80582 μM | SANGER | |||
| J-RT3-T3-5 | Growth Inhibition Assay | IC50=0.74403 μM | SANGER | |||
| VA-ES-BJ | Growth Inhibition Assay | IC50=0.73025 μM | SANGER | |||
| OCUB-M | Growth Inhibition Assay | IC50=0.70966 μM | SANGER | |||
| DU-145 | Growth Inhibition Assay | IC50=0.64745 μM | SANGER | |||
| NOS-1 | Growth Inhibition Assay | IC50=0.63723 μM | SANGER | |||
| MDA-MB-415 | Growth Inhibition Assay | IC50=0.63626 μM | SANGER | |||
| HT | Growth Inhibition Assay | IC50=0.63239 μM | SANGER | |||
| HAL-01 | Growth Inhibition Assay | IC50=0.6213 μM | SANGER | |||
| LNCaP-Clone-FGC | Growth Inhibition Assay | IC50=0.61048 μM | SANGER | |||
| HCC70 | Growth Inhibition Assay | IC50=0.59827 μM | SANGER | |||
| KE-37 | Growth Inhibition Assay | IC50=0.5826 μM | SANGER | |||
| MDA-MB-361 | Growth Inhibition Assay | IC50=0.57761 μM | SANGER | |||
| HGC-27 | Growth Inhibition Assay | IC50=0.56783 μM | SANGER | |||
| IGROV-1 | Growth Inhibition Assay | IC50=0.55249 μM | SANGER | |||
| BHT-101 | Growth Inhibition Assay | IC50=0.52961 μM | SANGER | |||
| H-EMC-SS | Growth Inhibition Assay | IC50=0.49939 μM | SANGER | |||
| HCC1419 | Growth Inhibition Assay | IC50=0.48892 μM | SANGER | |||
| NCI-H1563 | Growth Inhibition Assay | IC50=0.48189 μM | SANGER | |||
| A4-Fuk | Growth Inhibition Assay | IC50=0.46868 μM | SANGER | |||
| SBC-1 | Growth Inhibition Assay | IC50=0.44035 μM | SANGER | |||
| EFM-19 | Growth Inhibition Assay | IC50=0.4401 μM | SANGER | |||
| H9 | Growth Inhibition Assay | IC50=0.38883 μM | SANGER | |||
| NCI-H720 | Growth Inhibition Assay | IC50=0.37679 μM | SANGER | |||
| KARPAS-45 | Growth Inhibition Assay | IC50=0.37321 μM | SANGER | |||
| RS4-11 | Growth Inhibition Assay | IC50=0.3461 μM | SANGER | |||
| ES5 | Growth Inhibition Assay | IC50=0.34455 μM | SANGER | |||
| MOLT-16 | Growth Inhibition Assay | IC50=0.3032 μM | SANGER | |||
| HH | Growth Inhibition Assay | IC50=0.30283 μM | SANGER | |||
| T47D | Growth Inhibition Assay | IC50=0.2825 μM | SANGER | |||
| AsPC-1 | Growth Inhibition Assay | IC50=0.22122 μM | SANGER | |||
| MDA-MB-175-VII | Growth Inhibition Assay | IC50=0.13738 μM | SANGER | |||
| P12-ICHIKAWA | Growth Inhibition Assay | IC50=0.1162 μM | SANGER | |||
| NEC8 | Growth Inhibition Assay | IC50=0.09651 μM | SANGER | |||
| HONE-1 | Function Assay | 10 μM | 48 h | DMSO | Induces cell cycle arrest at G1 | 25336925 |
| CNE-2 | Function Assay | 10 μM | 48 h | DMSO | Induces cell cycle arrest at G1 | 25336925 |
| HONE-1 | Growth Inhibition Assay | 10 μM | 96 h | DMSO | IC50=3.37 μM | 25336925 |
| SUNE-1 | Growth Inhibition Assay | 10 μM | 96 h | DMSO | IC50=0.52 μM | 25336925 |
| CNE-2 | Growth Inhibition Assay | 10 μM | 96 h | DMSO | IC50=4.53 μM | 25336925 |
| CNE-1 | Growth Inhibition Assay | 10 μM | 96 h | DMSO | IC50=2.96 μM | 25336925 |
| GEO | Growth Inhibition Assay | 500 nM | 72 h | DMSO | Inhibits cell growth | 24581231 |
| HepG2 cell | Apoptosis Assay | 20 μM | 24 h | DMSO | Induces cell apoptosis | 23797319 |
| HepG2 cell | Growth Inhibition Assay | 30 μM | 24 h | DMSO | Inhibits cell growth | 23797319 |
| HepG2 cell | Kinase Assay | 20 μM | 24 h | DMSO | Downregulates the phosphorylation of AKT | 23797319 |
| CEM-S | Function Assay | 4 μM | 4 h | DMSO | Increases the amount of cleaved LC5A/B, a well-established autophagy marker | 22614243 |
| CEM-R | Function Assay | 4 μM | 4 h | DMSO | Increases the amount of cleaved LC4A/B, a well-established autophagy marker | 22614243 |
| MOLT-4 | Function Assay | 4 μM | 4 h | DMSO | Increases the amount of cleaved LC3A/B, a well-established autophagy marker | 22614243 |
| MOLT-4 | Function Assay | 10 μM | 24 h | DMSO | Blocks cells in the G0/G1 phase of the cell cycle | 22614243 |
| CEM-S | Cytotoxic Assay | 10 μM | 48 h | DMSO | IC50=5.1 μM | 22614243 |
| CEM-R | Cytotoxic Assay | 10 μM | 48 h | DMSO | IC50=3.3 μM | 22614243 |
| MOLT-4 | Cytotoxic Assay | 10 μM | 48 h | DMSO | IC50=1.7 μM | 22614243 |
| HC11 | Function Assay | 10 μM | 24 h | DMSO | Inhibits β-casein and ADRP synthesis | 22426621 |
| T98G | Apoptosis Assay | 0.5 μM | 60 h | DMSO | Augments apoptogenic effects of | 22057914 |
| TAD2 | Growth Inhibition Assay | 1000 μM | 5 d | DMSO | IC50>1000 μM | 21289267 |
| LN229 | Apoptosis Assay | 0.5 μM | 60 h | DMSO | Augments apoptogenic effects of | 22057914 |
| WRO | Growth Inhibition Assay | 1000 μM | 5 d | DMSO | IC50>1000 μM | 21289267 |
| SW1736 | Growth Inhibition Assay | 100 μM | 5 d | DMSO | IC50=47.56 μM | 21289267 |
| KAT18 | Growth Inhibition Assay | 3 μM | 5 d | DMSO | IC50=4.62 μM | 21289267 |
| Hth74 | Growth Inhibition Assay | 3 μM | 5 d | DMSO | IC50=2.19 μM | 21289267 |
| TPC1 cells harbored RET/PTC1 rearrangement | Growth Inhibition Assay | 3 μM | 5 d | DMSO | IC50=0.59 μM | 21289267 |
| Hth7 cells harbored NRAS (Q61R+/−) | Growth Inhibition Assay | 3 μM | 5 d | DMSO | IC50=4.5 μM | 21289267 |
| C643 cells harbored HRAS (G13R+/−) | Growth Inhibition Assay | 3 μM | 5 d | DMSO | IC50=0.27 μM | 21289267 |
| FTC133 cells harbored PTEN (allele deletion and R130+) | Growth Inhibition Assay | 3 μM | 5 d | DMSO | IC50=0.18 μM | 21289267 |
| K1 cells harbored PIK3CA (E542K+/+) | Growth Inhibition Assay | 3 μM | 5 d | DMSO | IC50=0.52 μM | 21289267 |
| OCUT1 cells harbored PIK3CA (H1047R+/+) | Growth Inhibition Assay | 3 μM | 5 d | DMSO | IC50=0.14 μM | 21289267 |
| Sk-Hep1 | Cytotoxic Assay | 10 μM | 24 h | DMSO | Sensitizes resistant cells to the cytotoxic effect of | 21205925 |
| HepG2 | Cytotoxic Assay | 10 μM | 24 h | DMSO | Sensitizes resistant cells to the cytotoxic effect of | 21205925 |
| A431 | Kinase Assay | 5 μM | 5 h | DMSO | Suppresses the signaling of Akt and Erk | 20571069 |
| NCI-H292 | Cytotoxic Assay | 3 μM | 72 h | DMSO | Inhibition of cell proliferation | 20571069 |
| HeLa | Function assay | 1 h | IC50 = 0.0228 μM | 29100733 | ||
| NCI-H460 | Growth inhibition assay | 72 h | IC50 = 5.4 μM | 24900862 | ||
| HCT116 | Growth inhibition assay | 72 h | IC50 = 7.5 μM | 24900862 | ||
| A673 | Function assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells | 29435139 | |||
| DAOY | Function assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells | 29435139 | |||
| Saos-2 | Function assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells | 29435139 | |||
| BT-37 | Function assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells | 29435139 | |||
| RD | Function assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells | 29435139 | |||
| SK-N-SH | Function assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells | 29435139 | |||
| BT-12 | Function assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells | 29435139 | |||
| MG 63 (6-TG R) | Function assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells | 29435139 | |||
| NB1643 | Function assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells | 29435139 | |||
| OHS-50 | Function assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells | 29435139 | |||
| Rh41 | Function assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells | 29435139 | |||
| Rh30 | Function assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells | 29435139 | |||
| SJ-GBM2 | Function assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells | 29435139 | |||
| SK-N-MC | Function assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells | 29435139 | |||
| NB-EBc1 | Function assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells | 29435139 | |||
| LAN-5 | Function assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells | 29435139 | |||
| Rh18 | Function assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells | 29435139 | |||
| 클릭하여 더 많은 세포주 실험 데이터 보기 | ||||||
| 분자량 | 480.39 | 화학식 | C25H21N5O.2HCl |
보관 (수령일로부터) | |
|---|---|---|---|---|---|
| CAS 번호 | 1032350-13-2 | SDF 다운로드 | 원액 보관 |
|
|
| 동의어 | N/A | Smiles | C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N.Cl.Cl | ||
|
In vitro |
DMSO
: 96 mg/mL
(199.83 mM)
Water : 96 mg/mL Ethanol : Insoluble |
|
In vivo |
|||||
1단계: 아래 정보 입력 (권장: 실험 중 손실을 고려하여 추가 동물 포함)
2단계: 생체 내 제형 입력 (이것은 계산기일 뿐 제형이 아닙니다. 용해도 섹션에 생체 내 제형이 없는 경우 먼저 당사에 문의하십시오.)
계산 결과:
작업 농도: mg/ml;
DMSO 원액 준비 방법: mg 약물 사전 용해 μL DMSO ( 원액 농도 mg/mL, 농도가 해당 약물 배치의 DMSO 용해도를 초과하는 경우 먼저 당사에 문의하십시오. )
생체 내 제형 준비 방법: 취하다 μL DMSO 원액, 다음 추가μL PEG300, 혼합하고 투명하게 한 다음 추가μL Tween 80, 혼합하고 투명하게 한 다음 추가 μL ddH2O, 혼합하고 투명하게 합니다.
생체 내 제형 준비 방법: 취하다 μL DMSO 원액, 다음 추가 μL 옥수수 기름, 혼합하고 투명하게 합니다.
참고: 1. 다음 용매를 추가하기 전에 액체가 투명한지 확인하십시오.
2. 용매를 순서대로 추가해야 합니다. 다음 용매를 추가하기 전에 이전 추가에서 얻은 용액이 투명한 용액인지 확인해야 합니다. 와동, 초음파 또는 뜨거운 물 중탕과 같은 물리적 방법을 사용하여 용해를 도울 수 있습니다.
| 특징 |
The first allosteric small molecule inhibitor of Akt to enter clinical development.
|
|---|---|
| Targets/IC50/Ki |
Akt1
(Cell-free assay) 8 nM
Akt2
(Cell-free assay) 12 nM
Akt3
(Cell-free assay) 65 nM
|
| 시험관 내(In vitro) |
MK-2206 2HCl은 알로스테릭 억제제이며 플렉스트린 상동성 도메인에 의해 활성화됩니다. 이 화합물은 Akt T308과 S473의 자가인산화를 모두 억제합니다. 또한 TSC2, PRAS40 및 리보솜 S6 단백질을 포함한 하류 신호 전달 분자의 Akt 매개 인산화를 방지합니다. 이 화학물질은 Ras 야생형 (WT) 세포주 (A431, HCC827 및 NCI-H292)를 Ras 돌연변이 세포주 (NCI-H358, NCI-H23, NCI-H1299 및 Calu-6)와 비교했을 때 더 강력하게 억제합니다. 또한 폐 NCI-H460 또는 난소 A2780 종양 세포에서 세포독성 제제와의 병용 시 시너지 반응을 보입니다. MK-2206 또는 siRNA 매개 Akt 억제는 인간 교모세포종 세포에서 autophagy를 강력하게 활성화합니다. 그러나 진핵세포 연장 인자-2 (eEF-2) 침묵은 이 화합물 유도 autophagy를 억제하며, apoptosis 세포 사멸을 촉진합니다. |
| 키나아제 분석 |
Akt 키나아제 분석
|
|
Akt 키나아제는 GSK 유래의 비오틴화된 펩타이드 기질로 분석됩니다. 펩타이드 인산화 정도는 HTRF(Homogeneous Time Resolved Fluorescence)를 사용하여 결정됩니다. HTRF는 인산화된 펩타이드에 특이적인 란타나이드 킬레이트(Lance) 결합 단일클론 항체와 펩타이드의 비오틴 부분에 결합하는 스트렙타비딘 결합 알로피코시아닌(SA-APC) 형광체를 함께 사용합니다. Lance와 APC가 가까이 있을 때, Lance에서 APC로 비방사성 에너지 전달이 일어나고, 이어서 655 nm에서 APC로부터 빛이 방출됩니다. 10X 분석 완충액: 500 mM HEPES, pH 7.5, 1% PEG, 16.6 mM EDTA, 1 mM EGTA, 1% BSA, 20 mM 9-글리세롤 인산; 퀀치 완충액: 50 mM HEPES pH 7.3, 16.6 mM EDTA, 0.1% BSA, 0.1% Triton X-100, 0.17 nM 표지 단일클론 항체, 0.0067 mg/mL SA-APC; ATP/MgCl2 작업 용액: 1X 분석 완충액, 1 mM DTT, 1X PIC, 5% 글리세롤, 활성 Akt; 펩타이드 작업 용액: 1X 분석 완충액, 1 mM DTT, 1X PIC, 5% 글리세롤, 2 TM GSK 비오틴화된 펩타이드. 반응은 적절한 웰에 16 µL의 ATP/MgCl2 작업 용액을 첨가하여 조립됩니다. MK-2206 2HCl 또는 운반체(1.0 µL)를 첨가한 다음 10 µL의 펩타이드 작업 용액을 첨가합니다. 반응은 13 μL의 효소 작업 용액을 첨가하고 혼합하여 시작됩니다. 반응은 50분 동안 진행되도록 허용된 다음 60 µL HTRF 퀀치 완충액을 첨가하여 중지됩니다. 중지된 반응은 실온에서 최소 30분 동안 배양한 다음 기기에서 판독됩니다.
|
|
| 생체 내(In vivo) |
MK-2206 2HCl은 240 mg/kg 용량에서 A2780 난소암 이종이식편에서 60% TGI를 보이며 phospho-Akt1/2 (T308 및 S473)의 70% 이상을 억제합니다. 이 화합물은 병용 시 NCI-H292 이종이식편에서 유의미한 항종양 활성을 나타냅니다. |
참조 |
|
| 방법 | 바이오마커 | 이미지 | PMID |
|---|---|---|---|
| Western blot | p-AKT(T308) / p-AKT(S473) / pGSK3β(S9) / pFOXO1 / pPRAS(T246) / pBAD / pS6K(T389) / p4E-BP1 |
|
22932669 |
| Growth inhibition assay | Cell viability |
|
24665203 |
| Immunofluorescence | LC3 CFTR/LC3 HMGA2 |
|
24490764 |
| ELISA | VEGFA |
|
29449553 |
(데이터 출처 https://clinicaltrials.gov, 업데이트 날짜 2024-05-22)
| NCT 번호 | 모집 | 조건 | 스폰서/협력자 | 시작일 | 단계 |
|---|---|---|---|---|---|
| NCT01480154 | Active not recruiting | Advanced Malignant Solid Neoplasm|Stage III Cutaneous Melanoma AJCC v7|Stage III Prostate Cancer AJCC v7|Stage III Renal Cell Cancer AJCC v7|Stage IIIA Cutaneous Melanoma AJCC v7|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7|Stage IV Prostate Cancer AJCC v7|Stage IV Renal Cell Cancer AJCC v7 |
National Cancer Institute (NCI) |
November 23 2011 | Phase 1 |
| NCT01466868 | Terminated | Diffuse Large B Cell Lymphoma |
Centre Leon Berard|National Cancer Institute France |
November 2011 | Phase 2 |
질문 1:
What is your recommendation for preparing its solution and how would you deliver it to the mice (i.p. or gavage)?
답변:
It can be resuspended in 15% Captisol at up to 17mg/ml. This suspension is for oral gavage use only.
질문 2:
I would want to know if it could cross the blood brain barrier?
답변:
It can cross BBB based on the following reference: https://clinicaltrials.gov/ct2/show/NCT01249105.